Jusforgues-Saklani H - Search Results

1

Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming.

Jusforgues-Saklani H, Uhl M, Blachère N, Lemaître F, Lantz O, Bousso P, Braun D, Moon JJ, Albert ML. Jusforgues-Saklani H, et al. J Immunol. 2008 Sep 1;181(5):3067-76. doi: 10.4049/jimmunol.181.5.3067. J Immunol. 2008. PMID: 18713977

2

Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.

Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML. Uhl M, et al. Among authors: jusforgues saklani h. Cell Death Differ. 2009 Jul;16(7):991-1005. doi: 10.1038/cdd.2009.8. Epub 2009 Feb 20. Cell Death Differ. 2009. PMID: 19229247

3

Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery.

Bouvier I, Jusforgues-Saklani H, Lim A, Lemaître F, Lemercier B, Auriau C, Nicola MA, Leroy S, Law HK, Bandeira A, Moon JJ, Bousso P, Albert ML. Bouvier I, et al. Among authors: jusforgues saklani h. Front Immunol. 2011 Dec 8;2:71. doi: 10.3389/fimmu.2011.00071. eCollection 2011. Front Immunol. 2011. PMID: 22566860 Free PMC article.

4

Tracking antigen-specific CD8⁺ T cells using MHC class I multimers.

Alanio C, Bouvier I, Jusforgues-Saklani H, Albert ML. Alanio C, et al. Among authors: jusforgues saklani h. Methods Mol Biol. 2013;960:309-326. doi: 10.1007/978-1-62703-218-6_23. Methods Mol Biol. 2013. PMID: 23329496

5

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

Biot C, Rentsch CA, Gsponer JR, Birkhäuser FD, Jusforgues-Saklani H, Lemaître F, Auriau C, Bachmann A, Bousso P, Demangel C, Peduto L, Thalmann GN, Albert ML. Biot C, et al. Among authors: jusforgues saklani h. Sci Transl Med. 2012 Jun 6;4(137):137ra72. doi: 10.1126/scitranslmed.3003586. Sci Transl Med. 2012. PMID: 22674550

6

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.

Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, Green DR, Oberst A, Albert ML. Yatim N, et al. Among authors: jusforgues saklani h. Science. 2015 Oct 16;350(6258):328-34. doi: 10.1126/science.aad0395. Epub 2015 Sep 24. Science. 2015. PMID: 26405229 Free PMC article.

7

Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins.

Klezovich-Bénard M, Corre JP, Jusforgues-Saklani H, Fiole D, Burjek N, Tournier JN, Goossens PL. Klezovich-Bénard M, et al. Among authors: jusforgues saklani h. PLoS Pathog. 2012 Jan;8(1):e1002481. doi: 10.1371/journal.ppat.1002481. Epub 2012 Jan 12. PLoS Pathog. 2012. PMID: 22253596 Free PMC article.

8

Purification of a 92 kDa human immunostimulating glycoprotein obtained from the Tamm-Horsfall glycoprotein.

Fontan E, Jusforgues-Saklani H, Briend E, Fauve RM. Fontan E, et al. Among authors: jusforgues saklani h. J Immunol Methods. 1995 Nov 16;187(1):81-4. doi: 10.1016/0022-1759(95)00169-b. J Immunol Methods. 1995. PMID: 7490460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page